Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- MHRA guidance on Coronavirus (COVID-19)
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Collection
MHRA guidance on coronavirus (COVID-19)
We are producing guidance for industry covering the coronavirus (COVID-19) outbreak.
Detailed guide
Guidance on coronavirus (COVID-19) tests and testing kits
Initial specifications for tests and testing kits and advice for members of the public.
Detailed guide
MHRA regulatory flexibilities resulting from coronavirus (COVID-19)
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Press release
UK medicines and medical devices regulator investigating 14 cases of fake or unlicensed COVID-19 medical products
An increasing number of bogus medical products being sold through unauthorised websites claiming to treat or prevent COVID-19 are being investigated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Guidance
Specification for Rapidly Manufactured CPAP System to be used during the coronavirus (COVID-19) outbreak
This is a specification of the minimally clinically acceptable Continuous Positive Airway Pressure (CPAP) system to be used in UK hospitals.
News story
Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment
Recent media reports have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus.
Latest from the Medicines and Healthcare products Regulatory Agency
- COVID-19: All haemofiltration systems including machines and accessories – serious risks if users don’t follow manufacturer instructions for set-up (MDA/2020/013)
- Managing clinical trials during Coronavirus (COVID-19)
- Approval of GxP documents when working from home during the coronavirus (COVID-19) outbreak
Subscriptions
Subscribe to feed
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Policy papers and consultations
- MHRA consultation on EU exit no-deal legislative proposals
- How should we engage and involve patients and the public in our work
Transparency and freedom of information releases
- Clinical trials for medicines: authorisation assessment performance
- MHRA: policy for handling conflicts of interest
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Please get in touch with us by phone or email during the coronavirus (COVID-19) response period.
Call 020 3080 6000 or email info@mhra.gov.uk over the Easter weekend, between 9am and 5pm, if you have an urgent COVID-19 or regulatory flexibility query.
Out of hours service will also be provided on 020 3080 6000 for emergency only situations related to COVID-19 and regulatory flexibilities.
In line with the Government’s advice, our building at 10 South Colonnade will close at 5pm on Friday 27 March. It will remain closed until at least week commencing Monday 13 April, at which point the decision will be reviewed.
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts